How We Grade

A grade is only worth reading if you know what produced it. Here is the whole method.

What JointBrex is

JointBrex reaches buyers through BuyGoods, with Instituto Experience of Lakeland, Florida named on the label as distributor. The Supplement Facts panel gives four lines: turmeric root extract at 4:1 (75 mg), a turmeric extract standardised to 95% curcuminoids (30 mg), Coleus Forskohlii extract (15 mg), and BioPerine (5 mg) — delivered in a gelatin capsule. The bottle's own claim is that it helps maintain a healthy inflammatory response.

The seven criteria

Label accuracy. Does every advertised ingredient appear on the panel, and do dose, capsule count, and allergen information agree between sources?

Dose adequacy. Do the amounts fall within the range used in published research on the ingredient?

Dose transparency. Can each active be quantified from the label, or do extracts hide behind ratios and unstated standardisation?

Ingredient selection. Is each ingredient a defensible choice for the stated purpose, on the evidence?

Absorption design. Where an ingredient has a known bioavailability problem, is it addressed?

Manufacturing claims. Are they accurate and appropriately stated, rather than implying approval that does not exist?

Refund terms. Are the window, conditions, and return costs stated up front and practically usable?

Why no criterion for effectiveness

Because we have not tested the product and no one has trialled this finished formula. Grading effectiveness would mean inventing a measurement. What we can grade is whether the formula is constructed in a way that could plausibly work, which is what these seven criteria measure.

Which document wins

The Supplement Facts panel, every time. It is a regulated disclosure with rules behind it; marketing copy is not. Where they conflict we grade the panel and count the conflict against label accuracy.

Where we estimated, we estimated favourably

Two label lines cannot be quantified. Rather than assuming the worst, we chose the assumptions most generous to the product — our 35 to 40 mg curcuminoid figure is at the optimistic end. The failing grade should not depend on us being harsh with arithmetic.

What we will not publish

We do not fabricate reviewers, invent star ratings, or quote customer counts. No aggregate rating markup sits in our code, because any figure in it would be one we could not stand behind. The reference sales page carries a thirty-minute countdown timer; we left it out, along with stock warnings and any saving we cannot demonstrate.

The obvious objection

We earn commission when someone buys through our links, and we have published a D grade. That looks contradictory and deserves a direct answer.

A scorecard that always returns a pass is not a scorecard, it is an advertisement with numbers on it. The value of publishing grades at all depends entirely on them being capable of coming out badly. A reader who buys anyway — understanding the dose, the label discrepancy, and the interaction cautions — will not feel misled later. A reader who decides against it has been served properly. The disclosure at the foot of every page exists so you can weigh our grades knowing exactly how we are paid.

Where not to rely on us

A hot or swollen joint, joint pain with fever, morning stiffness over an hour, or pain after an injury need a doctor, some of them promptly. No scorecard substitutes for that.